Nchi: Australia
Lugha: Kiingereza
Chanzo: APVMA (Australian Pesticides and Veterinary Medicines Authority)
LINCOMYCIN AS LINCOMYCIN HYDROCHLORIDE; SPECTINOMYCIN AS SPECTINOMYCIN SULFATE
ABBEY LABORATORIES PTY LTD
PARENTERAL LIQUID/SOLUTION/SUSPENSION
LINCOMYCIN AS LINCOMYCIN HYDROCHLORIDE ANTIBIOTIC Active 50.0 mg/ml; SPECTINOMYCIN AS SPECTINOMYCIN SULFATE ANTIBIOTIC Active 100.0 mg/ml
100 mL
VM - Veterinary Medicine
ANTIBIOTIC & RELATED
Poison schedule: 4; Withholding period: PIGS (MEAT): DO NOT USE less than 21 day s before slaughter for human consumption . BROILER CHICKENS (MEAT): DO NOT USE l ess than 10 days before slaughter for hu man consumption. Any variation by the p rescribing veterinarian to the approved dose, frequency, duration, route, diseas e or target species may require extendin g the approved withholding period. EXPO RT SLAUGHTER INTERVAL (ESI): An ESI has not been established for this product. Note—observing the meat withholding peri od may not be sufficient to mitigate pot ential risks to export trade. Trade advi ce should be sought from Abbey Animal He alth Pty Ltd on 02 8088 0720 before usi ng this product.; Host/pest details: CAT: [INFECTIONS OF THE URINARY TRACTS, INFECTIONS OF UPPER RESPIRATORY TRACT, LOCALISED INFECTIONS, SECONDARY INFECTION]; DOG: [INFECTIONS OF THE RESPIRATORY TRACT, INFECTIONS OF THE SKIN, INFECTIONS OF THE URINARY TRACTS, SECONDARY INFECTION]; PIGS: [ENTERITIS ASSOCIATED WITH E.COLI, MYCOPLASMAL PNEUMONIA, SWINE DYSENTERY]; POULTRY BROILERS (MEAT FOR HUMAN CONSUM): [CHRONIC RESPIRATORY DISEASE, ESCHERICHIA COLI (E. COLI), MYCOPLASMA GALLISEPTICUM]
Registered
2023-07-01
LINCO-SPEC INJECTION 86913/117018 Product Name: APVMA Approval No: Label Name: LINCO-SPEC INJECTION Signal Headings: PRESCRIPTION ANIMAL REMEDY KEEP OUT OF REACH OF CHILDREN FOR ANIMAL TREATMENT ONLY Constituent Statements: 100 mg/mL SPECTINOMYCIN (as Spectinomycin Sulphate) 50 mg/mL LINCOMYCIN (as Lincomycin hydrochloride) Claims: For use by or under direction of a registered veterinarian. For the treatment of infections in pigs, broiler chickens, dogs and cats caused by organisms sensitive to the action of Lincomycin and/or Spectinomycin. Pigs For treatment and control of swine dysentery (S. hyodysenteriae) and enteritis associated with E. coli. Aids in the control of Mycoplasma pneumonia. Broiler chickens For prevention and treatment of chronic respiratory disease in broiler chickens associated with Mycoplasma gallisepticum and E.coli. Dogs For treatment of respiratory infections, skin infections, urinary tract infections, and secondary bacterial infections, due to susceptible organisms, associated with virus diseases. Cats For treatment of urinary tract and upper respiratory tract infections, localised infections and secondary bacterial infections due to susceptible organisms, associated with virus diseases. Net Contents: 100 mL Directions for Use: Restraints: RLP APPROVED Contraindications: This product is contraindicated for use in animals previously found to be hypersensitive to either antibiotic or the combination. This product is contraindicated for use in animals with known pre-existing monilial infections. Precautions: Use in species other than those indicated may result in adverse gastrointestinal effects. At dose levels higher than those recommended, intramuscular administration to swine may cause transient diarrhoea or loose stools. This effect rarely has been reported at the recommended therapeutic dose level. An occasional report of pain on injection has been received; however, serious inflammatory reactions following injection have not been reported. Side Effects: Dosage and Administration: Use t Soma hati kamili